135 related articles for article (PubMed ID: 11720093)
1. A novel emulsifier, labrasol, enhances gastrointestinal absorption of gentamicin.
Hu Z; Tawa R; Konishi T; Shibata N; Takada K
Life Sci; 2001 Nov; 69(24):2899-910. PubMed ID: 11720093
[TBL] [Abstract][Full Text] [Related]
2. Diethyl ether fraction of Labrasol having a stronger absorption enhancing effect on gentamicin than Labrasol itself.
Hu Z; Prasad Yv R; Tawa R; Konishi T; Ishida M; Shibata N; Takada K
Int J Pharm; 2002 Mar; 234(1-2):223-35. PubMed ID: 11839453
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of oral formulations of gentamicin containing labrasol in beagle dogs.
Rama Prasad YV; Eaimtrakarn S; Ishida M; Kusawake Y; Tawa R; Yoshikawa Y; Shibata N; Takada K
Int J Pharm; 2003 Dec; 268(1-2):13-21. PubMed ID: 14643972
[TBL] [Abstract][Full Text] [Related]
4. Oral solid gentamicin preparation using emulsifier and adsorbent.
Ito Y; Kusawake T; Ishida M; Tawa R; Shibata N; Takada K
J Control Release; 2005 Jun; 105(1-2):23-31. PubMed ID: 15908031
[TBL] [Abstract][Full Text] [Related]
5. Labrasol® is an efficacious intestinal permeation enhancer across rat intestine: Ex vivo and in vivo rat studies.
McCartney F; Jannin V; Chevrier S; Boulghobra H; Hristov DR; Ritter N; Miolane C; Chavant Y; Demarne F; Brayden DJ
J Control Release; 2019 Sep; 310():115-126. PubMed ID: 31401199
[TBL] [Abstract][Full Text] [Related]
6. Absorption enhancing effect of labrasol on the intestinal absorption of insulin in rats.
Eaimtrakarn S; Rama Prasad YV; Ohno T; Konishi T; Yoshikawa Y; Shibata N; Takada K
J Drug Target; 2002 May; 10(3):255-60. PubMed ID: 12075827
[TBL] [Abstract][Full Text] [Related]
7. In situ intestinal absorption studies on low molecular weight heparin in rats using labrasol as absorption enhancer.
Rama Prasad YV; Minamimoto T; Yoshikawa Y; Shibata N; Mori S; Matsuura A; Takada K
Int J Pharm; 2004 Mar; 271(1-2):225-32. PubMed ID: 15129989
[TBL] [Abstract][Full Text] [Related]
8. Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats.
Lin Y; Shen Q; Katsumi H; Okada N; Fujita T; Jiang X; Yamamoto A
Biol Pharm Bull; 2007 Jul; 30(7):1301-7. PubMed ID: 17603171
[TBL] [Abstract][Full Text] [Related]
9. Enhancing effect of Labrasol on the intestinal absorption of ganciclovir in rats.
Shen Y; Lu Y; Jv M; Hu J; Li Q; Tu J
Drug Dev Ind Pharm; 2011 Dec; 37(12):1415-21. PubMed ID: 21623688
[TBL] [Abstract][Full Text] [Related]
10. Enhanced intestinal absorption of vancomycin with Labrasol and D-alpha-tocopheryl PEG 1000 succinate in rats.
Prasad YV; Puthli SP; Eaimtrakarn S; Ishida M; Yoshikawa Y; Shibata N; Takada K
Int J Pharm; 2003 Jan; 250(1):181-90. PubMed ID: 12480284
[TBL] [Abstract][Full Text] [Related]
11. Enhancing mechanism of Labrasol on intestinal membrane permeability of the hydrophilic drug gentamicin sulfate.
Koga K; Kusawake Y; Ito Y; Sugioka N; Shibata N; Takada K
Eur J Pharm Biopharm; 2006 Aug; 64(1):82-91. PubMed ID: 16750354
[TBL] [Abstract][Full Text] [Related]
12. Labrasol
Heade J; Maher S; Bleiel SB; Brayden DJ
J Pharm Sci; 2018 Jun; 107(6):1648-1655. PubMed ID: 29462634
[TBL] [Abstract][Full Text] [Related]
13. Absorption of interferon alpha from patches in rats.
Ito Y; Tosh B; Togashi Y; Amagase K; Kishida T; Kishida T; Sugioka N; Shibata N; Takada K
J Drug Target; 2005 Jul; 13(6):383-90. PubMed ID: 16278158
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in situ evidence for the contribution of Labrasol and Gelucire 44/14 on transport of cephalexin and cefoperazone by rat intestine.
Koga K; Kawashima S; Murakami M
Eur J Pharm Biopharm; 2002 Nov; 54(3):311-8. PubMed ID: 12445561
[TBL] [Abstract][Full Text] [Related]
15. Effects of Pluronic F68 and Labrasol on the intestinal absorption and pharmacokinetics of rifampicin in rats.
Ma L; Wei Y; Zhou Y; Ma X; Wu X
Arch Pharm Res; 2011 Nov; 34(11):1939-43. PubMed ID: 22139693
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and evaluation of a liposaccharide drug delivery agent: application to the gastrointestinal absorption of gentamicin.
Ross BP; DeCruz SE; Lynch TB; Davis-Goff K; Toth I
J Med Chem; 2004 Feb; 47(5):1251-8. PubMed ID: 14971905
[TBL] [Abstract][Full Text] [Related]
17. Permeabilities of rebamipide via rat intestinal membranes and its colon specific delivery using chitosan capsule as a carrier.
Huang BB; Li GF; Luo JH; Duan L; Nobuaki K; Akira Y
World J Gastroenterol; 2008 Aug; 14(31):4928-37. PubMed ID: 18756602
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Intestinal Transport and Absorption of Topotecan, a BCRP Substrate, by Various Pharmaceutical Excipients and Their Inhibitory Mechanisms of BCRP Transporter.
Sawangrat K; Yamashita S; Tanaka A; Morishita M; Kusamori K; Katsumi H; Sakane T; Yamamoto A
J Pharm Sci; 2019 Mar; 108(3):1315-1325. PubMed ID: 30389568
[TBL] [Abstract][Full Text] [Related]
19. Enhancing effect of glyceryl-1-monooctanoate on the rectal absorption of gentamicin from hollow-type suppositories in rabbits.
Matsumoto Y; Watanabe Y; Hori N; Naritomi S; Ku YS; Matsumoto M
Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2477-80. PubMed ID: 2605695
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the inhibition of intestinal glucuronidation in enhancing the oral bioavailability of resveratrol by labrasol containing nanoemulsions.
Zhou J; Zhou M; Yang FF; Liu CY; Pan RL; Chang Q; Liu XM; Liao YH
Mol Pharm; 2015 Apr; 12(4):1084-95. PubMed ID: 25723098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
